1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biguanides
        1.2.3 Sulphonylureas
        1.2.4 Thiazolidinediones
        1.2.5 Alpha-glucosidase Inhibitors
        1.2.6 DPP-4 Inhibitors
        1.2.7 GLP-1 Receptor Agonists
        1.2.8 SGLT-2 Inhibitors
        1.2.9 Insulins
    1.3 Market by Application
        1.3.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Type 2 Diabetes Medication Market Perspective (2017-2028)
    2.2 Type 2 Diabetes Medication Growth Trends by Region
        2.2.1 Type 2 Diabetes Medication Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Type 2 Diabetes Medication Historic Market Size by Region (2017-2022)
        2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028)
    2.3 Type 2 Diabetes Medication Market Dynamics
        2.3.1 Type 2 Diabetes Medication Industry Trends
        2.3.2 Type 2 Diabetes Medication Market Drivers
        2.3.3 Type 2 Diabetes Medication Market Challenges
        2.3.4 Type 2 Diabetes Medication Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Type 2 Diabetes Medication Players by Revenue
        3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2017-2022)
        3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2017-2022)
    3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue
    3.4 Global Type 2 Diabetes Medication Market Concentration Ratio
        3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2021
    3.5 Type 2 Diabetes Medication Key Players Head office and Area Served
    3.6 Key Players Type 2 Diabetes Medication Product Solution and Service
    3.7 Date of Enter into Type 2 Diabetes Medication Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Type 2 Diabetes Medication Breakdown Data by Type
    4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2017-2022)
    4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028)
5 Type 2 Diabetes Medication Breakdown Data by Application
    5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2017-2022)
    5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Type 2 Diabetes Medication Market Size (2017-2028)
    6.2 North America Type 2 Diabetes Medication Market Size by Type
        6.2.1 North America Type 2 Diabetes Medication Market Size by Type (2017-2022)
        6.2.2 North America Type 2 Diabetes Medication Market Size by Type (2023-2028)
        6.2.3 North America Type 2 Diabetes Medication Market Share by Type (2017-2028)
    6.3 North America Type 2 Diabetes Medication Market Size by Application
        6.3.1 North America Type 2 Diabetes Medication Market Size by Application (2017-2022)
        6.3.2 North America Type 2 Diabetes Medication Market Size by Application (2023-2028)
        6.3.3 North America Type 2 Diabetes Medication Market Share by Application (2017-2028)
    6.4 North America Type 2 Diabetes Medication Market Size by Country
        6.4.1 North America Type 2 Diabetes Medication Market Size by Country (2017-2022)
        6.4.2 North America Type 2 Diabetes Medication Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Type 2 Diabetes Medication Market Size (2017-2028)
    7.2 Europe Type 2 Diabetes Medication Market Size by Type
        7.2.1 Europe Type 2 Diabetes Medication Market Size by Type (2017-2022)
        7.2.2 Europe Type 2 Diabetes Medication Market Size by Type (2023-2028)
        7.2.3 Europe Type 2 Diabetes Medication Market Share by Type (2017-2028)
    7.3 Europe Type 2 Diabetes Medication Market Size by Application
        7.3.1 Europe Type 2 Diabetes Medication Market Size by Application (2017-2022)
        7.3.2 Europe Type 2 Diabetes Medication Market Size by Application (2023-2028)
        7.3.3 Europe Type 2 Diabetes Medication Market Share by Application (2017-2028)
    7.4 Europe Type 2 Diabetes Medication Market Size by Country
        7.4.1 Europe Type 2 Diabetes Medication Market Size by Country (2017-2022)
        7.4.2 Europe Type 2 Diabetes Medication Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2017-2028)
    8.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type
        8.2.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Type (2017-2028)
    8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Application
        8.3.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Application (2017-2028)
    8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region
        8.4.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Type 2 Diabetes Medication Market Size (2017-2028)
    9.2 Latin America Type 2 Diabetes Medication Market Size by Type
        9.2.1 Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022)
        9.2.2 Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028)
        9.2.3 Latin America Type 2 Diabetes Medication Market Share by Type (2017-2028)
    9.3 Latin America Type 2 Diabetes Medication Market Size by Application
        9.3.1 Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022)
        9.3.2 Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028)
        9.3.3 Latin America Type 2 Diabetes Medication Market Share by Application (2017-2028)
    9.4 Latin America Type 2 Diabetes Medication Market Size by Country
        9.4.1 Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022)
        9.4.2 Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2017-2028)
    10.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
        10.2.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Type (2017-2028)
    10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
        10.3.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Application (2017-2028)
    10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country
        10.4.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
        11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.1.5 AstraZeneca Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Type 2 Diabetes Medication Introduction
        11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
        11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.3.5 Novo Nordisk Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
        11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
        11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Details
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 Eli Lilly
        11.7.1 Eli Lilly Company Details
        11.7.2 Eli Lilly Business Overview
        11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
        11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.7.5 Eli Lilly Recent Developments
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Type 2 Diabetes Medication Introduction
        11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.8.5 Merck Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Type 2 Diabetes Medication Introduction
        11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.9.5 Sanofi Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Type 2 Diabetes Medication Introduction
        11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.10.5 Pfizer Recent Developments
    11.11 Astellas Pharma
        11.11.1 Astellas Pharma Company Details
        11.11.2 Astellas Pharma Business Overview
        11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
        11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.11.5 Astellas Pharma Recent Developments
    11.12 Daiichi Sankyo
        11.12.1 Daiichi Sankyo Company Details
        11.12.2 Daiichi Sankyo Business Overview
        11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
        11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.12.5 Daiichi Sankyo Recent Developments
    11.13 Biocon
        11.13.1 Biocon Company Details
        11.13.2 Biocon Business Overview
        11.13.3 Biocon Type 2 Diabetes Medication Introduction
        11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.13.5 Biocon Recent Developments
    11.14 Glenmark
        11.14.1 Glenmark Company Details
        11.14.2 Glenmark Business Overview
        11.14.3 Glenmark Type 2 Diabetes Medication Introduction
        11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.14.5 Glenmark Recent Developments
    11.15 Bayer AG
        11.15.1 Bayer AG Company Details
        11.15.2 Bayer AG Business Overview
        11.15.3 Bayer AG Type 2 Diabetes Medication Introduction
        11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.15.5 Bayer AG Recent Developments
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Type 2 Diabetes Medication Introduction
        11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.16.5 Takeda Recent Developments
    11.17 Sun pharma
        11.17.1 Sun pharma Company Details
        11.17.2 Sun pharma Business Overview
        11.17.3 Sun pharma Type 2 Diabetes Medication Introduction
        11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.17.5 Sun pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biguanides
    Table 3. Key Players of Sulphonylureas
    Table 4. Key Players of Thiazolidinediones
    Table 5. Key Players of Alpha-glucosidase Inhibitors
    Table 6. Key Players of DPP-4 Inhibitors
    Table 7. Key Players of GLP-1 Receptor Agonists
    Table 8. Key Players of SGLT-2 Inhibitors
    Table 9. Key Players of Insulins
    Table 10. Global Type 2 Diabetes Medication Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Type 2 Diabetes Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Type 2 Diabetes Medication Market Share by Region (2017-2022)
    Table 14. Global Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Type 2 Diabetes Medication Market Share by Region (2023-2028)
    Table 16. Type 2 Diabetes Medication Market Trends
    Table 17. Type 2 Diabetes Medication Market Drivers
    Table 18. Type 2 Diabetes Medication Market Challenges
    Table 19. Type 2 Diabetes Medication Market Restraints
    Table 20. Global Type 2 Diabetes Medication Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Type 2 Diabetes Medication Revenue Share by Players (2017-2022)
    Table 22. Global Top Type 2 Diabetes Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021)
    Table 23. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Type 2 Diabetes Medication Product Solution and Service
    Table 27. Date of Enter into Type 2 Diabetes Medication Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Type 2 Diabetes Medication Revenue Market Share by Type (2017-2022)
    Table 31. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Type 2 Diabetes Medication Revenue Market Share by Type (2023-2028)
    Table 33. Global Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Type 2 Diabetes Medication Revenue Share by Application (2017-2022)
    Table 35. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Type 2 Diabetes Medication Revenue Share by Application (2023-2028)
    Table 37. North America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million)
    Table 67. AstraZeneca Company Details
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca Type 2 Diabetes Medication Product
    Table 70. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 71. AstraZeneca Recent Developments
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Type 2 Diabetes Medication Product
    Table 75. Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 76. Novartis Recent Developments
    Table 77. Novo Nordisk Company Details
    Table 78. Novo Nordisk Business Overview
    Table 79. Novo Nordisk Type 2 Diabetes Medication Product
    Table 80. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 81. Novo Nordisk Recent Developments
    Table 82. Johnson & Johnson Company Details
    Table 83. Johnson & Johnson Business Overview
    Table 84. Johnson & Johnson Type 2 Diabetes Medication Product
    Table 85. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 86. Johnson & Johnson Recent Developments
    Table 87. Boehringer Ingelheim Company Details
    Table 88. Boehringer Ingelheim Business Overview
    Table 89. Boehringer Ingelheim Type 2 Diabetes Medication Product
    Table 90. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 91. Boehringer Ingelheim Recent Developments
    Table 92. Bristol-Myers Squibb Company Details
    Table 93. Bristol-Myers Squibb Business Overview
    Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product
    Table 95. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 96. Bristol-Myers Squibb Recent Developments
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Type 2 Diabetes Medication Product
    Table 100. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 101. Eli Lilly Recent Developments
    Table 102. Merck Company Details
    Table 103. Merck Business Overview
    Table 104. Merck Type 2 Diabetes Medication Product
    Table 105. Merck Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 106. Merck Recent Developments
    Table 107. Sanofi Company Details
    Table 108. Sanofi Business Overview
    Table 109. Sanofi Type 2 Diabetes Medication Product
    Table 110. Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 111. Sanofi Recent Developments
    Table 112. Pfizer Company Details
    Table 113. Pfizer Business Overview
    Table 114. Pfizer Type 2 Diabetes Medication Product
    Table 115. Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 116. Pfizer Recent Developments
    Table 117. Astellas Pharma Company Details
    Table 118. Astellas Pharma Business Overview
    Table 119. Astellas Pharma Type 2 Diabetes Medication Product
    Table 120. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 121. Astellas Pharma Recent Developments
    Table 122. Daiichi Sankyo Company Details
    Table 123. Daiichi Sankyo Business Overview
    Table 124. Daiichi Sankyo Type 2 Diabetes Medication Product
    Table 125. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 126. Daiichi Sankyo Recent Developments
    Table 127. Biocon Company Details
    Table 128. Biocon Business Overview
    Table 129. Biocon Type 2 Diabetes Medication Product
    Table 130. Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 131. Biocon Recent Developments
    Table 132. Glenmark Company Details
    Table 133. Glenmark Business Overview
    Table 134. Glenmark Type 2 Diabetes Medication Product
    Table 135. Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 136. Glenmark Recent Developments
    Table 137. Bayer AG Company Details
    Table 138. Bayer AG Business Overview
    Table 139. Bayer AG Type 2 Diabetes Medication Product
    Table 140. Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 141. Bayer AG Recent Developments
    Table 142. Takeda Company Details
    Table 143. Takeda Business Overview
    Table 144. Takeda Type 2 Diabetes Medication Product
    Table 145. Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 146. Takeda Recent Developments
    Table 147. Sun pharma Company Details
    Table 148. Sun pharma Business Overview
    Table 149. Sun pharma Type 2 Diabetes Medication Product
    Table 150. Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million)
    Table 151. Sun pharma Recent Developments
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type 2 Diabetes Medication Market Share by Type: 2021 VS 2028
    Figure 2. Biguanides Features
    Figure 3. Sulphonylureas Features
    Figure 4. Thiazolidinediones Features
    Figure 5. Alpha-glucosidase Inhibitors Features
    Figure 6. DPP-4 Inhibitors Features
    Figure 7. GLP-1 Receptor Agonists Features
    Figure 8. SGLT-2 Inhibitors Features
    Figure 9. Insulins Features
    Figure 10. Global Type 2 Diabetes Medication Market Share by Application: 2021 VS 2028
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Retail Pharmacies Case Studies
    Figure 13. Online Pharmacies Case Studies
    Figure 14. Type 2 Diabetes Medication Report Years Considered
    Figure 15. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Type 2 Diabetes Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Type 2 Diabetes Medication Market Share by Region: 2021 VS 2028
    Figure 18. Global Type 2 Diabetes Medication Market Share by Players in 2021
    Figure 19. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2021
    Figure 21. North America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
    Figure 23. North America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
    Figure 24. North America Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
    Figure 25. United States Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
    Figure 31. Germany Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Type 2 Diabetes Medication Market Size Share by Region (2017-2028)
    Figure 41. China Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
    Figure 51. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Type 2 Diabetes Medication Market Size Share by Country (2017-2028)
    Figure 57. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 62. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 66. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 67. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 68. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 69. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 70. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 71. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 72. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 73. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 74. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 75. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 76. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed